Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.

Manolis, Antonis A

Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2. [electronic resource] - Expert opinion on drug safety 09 2018 - 893-915 p. digital

Publication Type: Journal Article; Review

1744-764X

10.1080/14740338.2018.1513489 doi


Aging
Animals
Antineoplastic Agents--administration & dosage
Cardiotoxicity--diagnosis
Cardiovascular Diseases--chemically induced
Dose-Response Relationship, Drug
Humans
Molecular Targeted Therapy
Neoplasms--drug therapy
Risk Factors